<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v8i7.7856</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>The Effectiveness of Albumin Combined with Diuretics in Treating Ascites in Cirrhosis</title><url>https://artdesignp.com/journal/JCNR/8/7/10.26689/jcnr.v8i7.7856</url><author>AnYajun</author><pub-date pub-type="publication-year"><year>2024</year></pub-date><volume>8</volume><issue>7</issue><history><date date-type="pub"><published-time>2024-08-09</published-time></date></history><abstract>Cirrhosis often leads to various complications during its progression, with ascites being one of the most common. Among these cases, 5% to 10% are classified as refractory ascites. In recent years, clinical research on the treatment of cirrhotic ascites has yielded increasingly enriched results. In this paper, a large number of clinical data on the treatment of ascites using albumin combined with diuretics were collected, and it was found that there were more results in group control studies. It was believed that albumin combined with diuretic therapy could effectively improve symptoms, reduce the occurrence of adverse reactions, ensure the safety of patients, and have a good clinical application prospect. This paper reviews the efficacy of albumin combined with diuretics in the treatment of ascites in cirrhosis.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Liu L, Huang X, Yang C, et al., 2017, Clinical Effect of Zhigancao Decoction Combined with Zhuling Decoction in Treating Ascites with Cirrhosis. Chinese Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2017(02): 93–96.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Shi LQ, Wang XJ, Zhou F, et al., 2011, Antiviral Drugs Combined with the Denver Tube in the Treatment of HBV-Related Cirrhosis Refractory Ascites: Two Cases Report. Chinese Journal of Hepatology, 19(12): 947–948.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Bae IH, Kim G, Jeong SH, et al., 2022, A Case Study of a Patient Who Discontinued Diuretics due to Hyponatremia and Was Treated with Korean Medicine for Ascites. The Journal of Internal Korean Medicine, 43(6): 1198–1207.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Yan F, Chen L, Ying M, et al., 2024, Efficacy and Safety of Pembrolizumab Combined with Albumin-Bound Paclitaxel and Nedaplatin for Advanced Esophageal Squamous Cell Carcinoma. Immunotherapy, 2024(5): 16.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Shu J, Wang X, Fan J, et al., 2024, Efficacy and Safety of Remimazolam Tosilate Combined with Butorphanol Tartrate for Painless Abortion and the Effect of Postoperative Nursing Combined with Buxue Yimu Granule on Nutritional Status of Patient. Current Topics in Nutraceutical Research, 2024(1): 22.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Fu W, Shentu C, Chen D, et al., 2024, Network Pharmacology Combined with Affinity Ultrafiltration to Elucidate the Potential Compounds of Shaoyao Gancao Fuzi Decoction for the Treatment of Rheumatoid Arthritis. Journal of Ethnopharmacology, 2024: 330.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Tsukishiro Y, Yamamoto H, Masumoto A, et al., 2023, Cell-Free and Concentrated Ascites Reinfusion Therapy for Refractory Massive Cardiac Ascites in an Adult with Single Ventricle Hemodynamics: A Case Report. European Heart Journal Case Reports, 7(3): ytad081.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Macken L, Corrigan M, Prentice W, et al., 2022, Palliative Long-Term Abdominal Drains for the Management of Refractory Ascites Due to Cirrhosis: A Consensus Document. Frontline Gastroenterology, 13(e1): e116–e125.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Tapper EB, Parikh ND, 2023, Diagnosis and Management of Cirrhosis and Its Complications A Review. Journal of the American Medical Association, 2023(18): 329.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Wang R, Chai L, Guo X, 2022, Diuretics in Cirrhotic Patients with Ascites, in Qi X, Yang Y, (eds), Pharmacotherapy for Liver Cirrhosis and Its Complications, Springer, Singapore.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Gonzalez JJ, Dziwis J, Patel YA, et al., 2022, Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study. Digestive Diseases and Sciences, 67(10): 4695–4701.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Nakai M, Morikawa K, Sasaki T, et al., 2023, Neutrophil Gelatinase-Associated Lipocalin Predicts the Efficacy of Tolvaptan for Ascites in Patients with Liver Cirrhosis. Journal of Gastroenterology, 58(7): 656–667.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
